Fund Holdings — Merck & Co., Inc.

Total Portfolio Value:
$215.60M
Total Bought:
$31.1K
Total Sold:
$0
Net Transaction:
+$31.1K
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Personalis, Inc.(PSNL)14,044,94314,044,9430$49.30M$92.13M42.73%+$42.84M
Moderna, Inc.(MRNA)2,308,1902,308,1900$65.44M$63.68M29.54%-$1.75M
Kymera Therapeutics, Inc.(KYMR)772,165772,1650$21.13M$33.70M15.63%+$12.56M
Entrada Therapeutics, Inc.(TRDA)1,739,7681,739,7680$15.73M$11.69M5.42%-$4.04M
Alector Inc3,545,7193,545,7190$4.36M$4.96M2.30%+$602.8K
Evaxion Biotech A/sADS1,214,1261,214,1260$2.25M$2.97M1.38%+$728.5K
Sutro Biopharma, Inc.(STRO)2,723,5092,723,5090$1.77M$1.94M0.90%+$172.4K
Lava Therapeutics NvSHS1,149,3451,149,3450$1.46M$1.52M0.70%+$57.5K
Viridian Therapeutics, Inc.(VRDN)93,41493,4140$1.26M$1.31M0.61%+$46.7K
Xilio Therapeutics, Inc.(XLO)1,483,7581,483,7580$1.07M$1.01M0.47%-$66.0K
Carisma Therapeutics Inc1,473,2401,473,2400$456.7K$576.9K0.27%+$120.2K
Neuphoria Therapeutics Inc10,02710,0270$57.8K$71.2K0.03%+$13.4K
TuHURA Biosciences, Inc.(HURA)013,950+13,950$0$31.1K0.01%+$31.1K
Page 1 of 1
Merck & Co., Inc. — 13F Holdings — Q2 2025 | TickerTrail